Drug Channels Archive for April, 2025

Click a link below to view the mailing archive as if it had been sent to you.

2025-04-17 07:47		Drug Channels - The AI Advantage: When and Where to Apply It in Your Patient Support Program
2025-04-16 07:36		Drug Channels - The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market
2025-04-15 08:02		Drug Channels - Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules
2025-04-11 07:47		Drug Channels - The Hidden Costs of Data Silos: How Pharma Manufacturers Can Stop Revenue Leaks and Strengthen Security
2025-04-09 07:17		Drug Channels - Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI's 2025 Update and Competitive Outlook
2025-04-04 07:52		Drug Channels - Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns (rerun)
2025-04-03 08:00		Drug Channels - Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (rerun)
2025-04-02 07:41		Drug Channels - Four Revelations from Minnesota's First 340B Transparency Report (rerun)
2025-04-01 07:14		Drug Channels - The Big Three PBMs' 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars (rerun)